<p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) 的股票在經歷了一段動盪期後，最近一個月表現非常出色，漲幅達到 78%。然而，30 天的漲幅並不能改變長期股東在過去 12 個月中因股價下跌 67% 而遭受重創的事實。</p>
<p>儘管價格有了明顯反彈，但考慮到美國保險行業約一半的公司市銷率（或稱 &#34;P/S&#34;）超過 1.1 倍，您仍然可以將 Reliance Global Group 視為一個有吸引力的投資，因其市銷率為 0.5 倍。然而，市銷率低可能是有原因的，需要進一步調查以確定其合理性。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>查看我們對 Reliance Global Group 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784"/></p>
<p>NasdaqCM:RELI 市銷率與行業比較 2025 年 6 月 18 日</p>
<h3>Reliance Global Group 最近的表現如何？</h3>
<p>我們不得不説，在過去一年中幾乎沒有實質性增長的情況下，Reliance Global Group 的收入表現並不令人印象深刻。一個可能性是，市銷率低是因為投資者認為這種温和的收入增長率在不久的將來可能會落後於更廣泛的行業。如果不是這樣，那麼現有股東可能對股價的未來走勢感到樂觀。</p>
<p>我們沒有分析師的預測，但您可以通過查看我們關於 Reliance Global Group 的 <strong>免費</strong> 報告，瞭解最近的趨勢如何為公司未來鋪路，包括其收益、收入和現金流。</p>
<h2>收入增長指標告訴我們關於低市銷率的什麼？</h2>
<p>您唯一會真正感到舒適的情況是，當公司的增長預計將落後於行業時，市銷率低至 Reliance Global Group 的水平。</p>
<p>回顧過去，我們看到公司在過去一年幾乎沒有可言的收入增長。然而，在此之前的幾年強勁表現使得它在過去三年中總收入增長了令人印象深刻的 36%。因此，可以公平地説，最近的收入增長對公司來説是很好的，但投資者會想問為什麼增長速度減緩到如此程度。</p>
<p>與行業一年增長預測 5.2% 相比，最近的中期收入軌跡顯得更加誘人。</p>
<p>考慮到這一點，我們發現 Reliance Global Group 的市銷率與其行業同行相比並不高。顯然，一些股東認為最近的表現已經超出了其極限，並接受了顯著較低的售價。</p>
<p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>關鍵要點</h2>
<p>儘管 Reliance Global Group 的股價最近上漲，但其市銷率仍落後於大多數其他公司。僅僅使用市銷率來判斷您是否應該賣出股票並不明智，但它可以作為公司未來前景的實用指南。</p>
<p>我們對 Reliance Global Group 的審查顯示，其三年收入趨勢並沒有像我們預期的那樣大幅提升其市銷率，儘管這些趨勢看起來好於當前行業預期。當我們看到強勁的收入和快於行業的增長時，我們假設公司盈利能力存在一些重大潛在風險，這對市銷率施加了向下壓力。如果最近的中期收入趨勢持續，價格風險看起來非常低，但投資者似乎認為未來收入可能會出現較大波動。</p>
<p>此外，您還應該瞭解我們發現的 <strong>Reliance Global Group 的 5 個警示信號</strong>。</p>
<p>如果您對 Reliance Global Group 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的基本面穩健的其他公司呢？</p>

RELI

EZRA

<p>Reliance Global Group, Inc.（納斯達克代碼：RELI）的股價最近飆升了 78%，然而長期投資者在過去一年中面臨 67% 的下跌。儘管其市銷率（P/S）僅為 0.5 倍，顯示出潛在的吸引力，但收入增長卻停滯不前。該公司的近期表現引發了人們對其能否與行業增長預期競爭的擔憂。分析師指出，低市銷率可能反映了投資者對未來收入穩定性的懷疑。儘管近期股價上漲，但仍需謹慎，因為潛在風險可能影響盈利能力</p>

<p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) shares have had a really impressive month, gaining 78% after a shaky period beforehand. Still, the 30-day jump doesn't change the fact that longer term shareholders have seen their stock decimated by the 67% share price drop in the last twelve months.</p>
<div class="lb-trans"><p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) 的股票在經歷了一段動盪期後，最近一個月表現非常出色，漲幅達到 78%。然而，30 天的漲幅並不能改變長期股東在過去 12 個月中因股價下跌 67% 而遭受重創的事實。</p>
</div><p>In spite of the firm bounce in price, given about half the companies operating in the United States' Insurance industry have price-to-sales ratios (or &#34;P/S&#34;) above 1.1x, you may still consider Reliance Global Group as an attractive investment with its 0.5x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>儘管價格有了明顯反彈，但考慮到美國保險行業約一半的公司市銷率（或稱 &#34;P/S&#34;）超過 1.1 倍，您仍然可以將 Reliance Global Group 視為一個有吸引力的投資，因其市銷率為 0.5 倍。然而，市銷率低可能是有原因的，需要進一步調查以確定其合理性。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>See our latest analysis for Reliance Global Group</p>
<div class="lb-trans"><p>查看我們對 Reliance Global Group 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784" alt="" original-src="https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784"/></p>
<p>NasdaqCM:RELI Price to Sales Ratio vs Industry June 18th 2025</p>
<div class="lb-trans"><p>NasdaqCM:RELI 市銷率與行業比較 2025 年 6 月 18 日</p>
</div><h3>What Does Reliance Global Group's Recent Performance Look Like?</h3>
<div class="lb-trans"><h3>Reliance Global Group 最近的表現如何？</h3>
</div><p>We'd have to say that with no tangible growth over the last year, Reliance Global Group's revenue has been unimpressive. One possibility is that the P/S is low because investors think this benign revenue growth rate will likely underperform the broader industry in the near future. If not, then existing shareholders may be feeling optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>我們不得不説，在過去一年中幾乎沒有實質性增長的情況下，Reliance Global Group 的收入表現並不令人印象深刻。一個可能性是，市銷率低是因為投資者認為這種温和的收入增長率在不久的將來可能會落後於更廣泛的行業。如果不是這樣，那麼現有股東可能對股價的未來走勢感到樂觀。</p>
</div><p>We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our <strong>free</strong> report on Reliance Global Group's earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>我們沒有分析師的預測，但您可以通過查看我們關於 Reliance Global Group 的 <strong>免費</strong> 報告，瞭解最近的趨勢如何為公司未來鋪路，包括其收益、收入和現金流。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The Low P/S?</h2>
<div class="lb-trans"><h2>收入增長指標告訴我們關於低市銷率的什麼？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as low as Reliance Global Group's is when the company's growth is on track to lag the industry.</p>
<div class="lb-trans"><p>您唯一會真正感到舒適的情況是，當公司的增長預計將落後於行業時，市銷率低至 Reliance Global Group 的水平。</p>
</div><p>Taking a look back first, we see that there was hardly any revenue growth to speak of for the company over the past year. However, a few strong years before that means that it was still able to grow revenue by an impressive 36% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been great for the company, but investors will want to ask why it has slowed to such an extent.</p>
<div class="lb-trans"><p>回顧過去，我們看到公司在過去一年幾乎沒有可言的收入增長。然而，在此之前的幾年強勁表現使得它在過去三年中總收入增長了令人印象深刻的 36%。因此，可以公平地説，最近的收入增長對公司來説是很好的，但投資者會想問為什麼增長速度減緩到如此程度。</p>
</div><p>When compared to the industry's one-year growth forecast of 5.2%, the most recent medium-term revenue trajectory is noticeably more alluring</p>
<div class="lb-trans"><p>與行業一年增長預測 5.2% 相比，最近的中期收入軌跡顯得更加誘人。</p>
</div><p>With this in mind, we find it intriguing that Reliance Global Group's P/S isn't as high compared to that of its industry peers. Apparently some shareholders believe the recent performance has exceeded its limits and have been accepting significantly lower selling prices.</p>
<div class="lb-trans"><p>考慮到這一點，我們發現 Reliance Global Group 的市銷率與其行業同行相比並不高。顯然，一些股東認為最近的表現已經超出了其極限，並接受了顯著較低的售價。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png" alt="" original-src="https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><p>Despite Reliance Global Group's share price climbing recently, its P/S still lags most other companies. Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>儘管 Reliance Global Group 的股價最近上漲，但其市銷率仍落後於大多數其他公司。僅僅使用市銷率來判斷您是否應該賣出股票並不明智，但它可以作為公司未來前景的實用指南。</p>
</div><p>Our examination of Reliance Global Group revealed its three-year revenue trends aren't boosting its P/S anywhere near as much as we would have predicted, given they look better than current industry expectations. When we see strong revenue with faster-than-industry growth, we assume there are some significant underlying risks to the company's ability to make money which is applying downwards pressure on the P/S ratio. At least price risks look to be very low if recent medium-term revenue trends continue, but investors seem to think future revenue could see a lot of volatility.</p>
<div class="lb-trans"><p>我們對 Reliance Global Group 的審查顯示，其三年收入趨勢並沒有像我們預期的那樣大幅提升其市銷率，儘管這些趨勢看起來好於當前行業預期。當我們看到強勁的收入和快於行業的增長時，我們假設公司盈利能力存在一些重大潛在風險，這對市銷率施加了向下壓力。如果最近的中期收入趨勢持續，價格風險看起來非常低，但投資者似乎認為未來收入可能會出現較大波動。</p>
</div><p>Plus, you should also learn about these <strong>5 warning signs we've spotted with Reliance Global Group</strong>.</p>
<div class="lb-trans"><p>此外，您還應該瞭解我們發現的 <strong>Reliance Global Group 的 5 個警示信號</strong>。</p>
</div><p>If you're <strong>unsure about the strength of Reliance Global Group's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您對 Reliance Global Group 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的基本面穩健的其他公司呢？</p>
</div>

儘管 Reliance Global Group, Inc.（納斯達克代碼：RELI）的股價上漲了 78%，投資者仍然對其收入不完全信服